Comments on: Aducanumab: will Biogen’s Aduhelm recover from its rocky start? /features/aducanumab-biogen-aduhelm-recover-rocky-start/ The leading site for news and procurement in the pharmaceutical industry Fri, 19 Nov 2021 13:01:27 +0000 hourly 1 https://wordpress.org/?v=6.6.2